Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) reported its financial results for 2024 late after the market closed on Tuesday. The company saw its fourth quarter sales reach C$18...
Cannabis industry insiders may have grown weary of peering into their crystal balls to determine whether federal reform of any kind is on the horizon during...
The newest U.S. state recreational marijuana market appears to be on hold indefinitely. Delaware legislators, after legalizing adult-use cannabis in 2023, are being forced to revisit...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) reported a net loss of $4.97 million for 2024 while the botanical psychedelic drug developer expanded its clinical...
Illinois marijuana sales took a 7% month-over-month dip in February, falling to $150.3 million from January’s tally of $161.7 million, according to statistics from the state...
A New Hampshire state Senate committee dealt a likely death blow to a trio of pro-marijuana bills, voting down each of them during a hearing this...
Safe Harbor Financial (NASDAQ: SHFS) reported mixed financial results for the fourth quarter and full year of 2024 that ended Dec. 31, with revenue declines offset...
Grown Rogue International (CSE: GRIN) (OTC: GRUSF) reported a 16% increase in annual revenue for 2024, reaching $27 million versus $23.4 million in the previous fiscal...
1933 Industries (CSE: TGIF) (OTC PINK: TGIFF) released financial results for its fiscal second quarter, which ended Jan. 31, telling investors that revenue increased sequentially. 1933 reported...
HOPE Therapeutics, an interventional psychiatry network wholly owned by NRx Pharmaceuticals (Nasdaq: NRXP), today announced it was buying Dura Medical per the previously announced non-binding letter of...